← Back to Clinical Trials
Recruiting NCT07498530

Virtual Assistant for Exercise Adherence in Older ADULTS

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Older Adult
Sponsor University of Valencia
Study Type INTERVENTIONAL
Phase N/A
Enrollment 70
Sex ALL
Min Age 59 Years
Max Age N/A
Start Date 2026-02-01
Completion 2026-12-30
Interventions
Exercise program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will evaluate the effectiveness of a virtual assistant-guided exercise program to improve adherence in older adults. In a nonrandomized controlled clinical trial, the experimental group will complete a 12-week, home-based program (60-minute sessions, 3 times per week) supported by a virtual assistant (BOT). The control group will comprise community-dwelling older adults already engaged in the municipal program Enguera se saludable, which delivers an in-person exercise program of comparable frequency and duration. The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed. Secondary outcomes include muscle strength, balance, functional capacity, health-related quality of life, and the user experience and usability of the virtual assistant.

Eligibility Criteria

Inclusion Criteria: * Adults aged 60 years or older. * Community-dwelling individuals capable of participating in an exercise program. * Ability to complete 60-minute exercise sessions, three times per week during the 12-week intervention. * Experimental group (BOT Group): Participants willing to use a smartphone/tablet and interact with the virtual assistant. * Control group (Municipal Exercise Group): Individuals already enrolled in the municipal program Enguera se saludable. * Ability to understand the study procedures and provide written informed consent Exclusion Criteria: * Medical contraindications to physical exercise, as determined by clinical judgment (e.g., uncontrolled cardiovascular, respiratory, or metabolic conditions). * Severe cognitive impairment or neurological conditions that limit the ability to follow instructions or safely perform the exercise program. * Severe mobility limitations preventing participation in structured exercise (e.g., inability to walk independe

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}